Metronidazol Normon

Metronidazole, the active ingredient in Metronidazol Normon, is a nitroimidazole antibiotic presented as a sterile solution for intravenous use. It treats anaerobic bacterial infections and certain protozoal infections in adult patients, including intra‑abdominal and pelvic infections.

GNH USA supplies Metronidazol Normon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and procurement teams worldwide with reliable, quality‑assured products. The company adheres to stringent regulatory standards and provides comprehensive documentation for global distribution.

Metronidazole is indicated for a range of anaerobic bacterial and protozoal infections.

- Anaerobic bacterial infections: eradicates susceptible anaerobes, reducing infection severity. - Intra‑abdominal infections: controls mixed flora, aiding resolution of peritonitis. - Pelvic inflammatory disease: eliminates anaerobic pathogens contributing to pelvic inflammation. - Bacterial vaginosis: restores normal vaginal flora by targeting Gardnerella and related organisms. - Trichomoniasis: kills Trichomonas vaginalis, relieving symptoms. - Clostridioides difficile‑associated diarrhea: suppresses toxin‑producing C. difficile strains, helping restore gut balance.

Metronidazole may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: transient metallic sensation in the mouth. - Headache: mild to moderate headache. - Diarrhea: loose stools, usually self‑limited. - Abdominal pain: cramping or discomfort. - Dizziness: occasional light‑headedness.

Serious or Rare Side Effects: - Seizures: rare neurologic events. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reactions: rash, itching, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: serious skin reactions. - Hepatotoxicity: elevated liver enzymes or liver injury. - Neutropenia: reduced white blood cell count.

Before initiating therapy, consider the following safety measures.

- Assess renal function: adjust therapy in patients with impaired clearance. - Monitor hepatic function: watch for liver enzyme elevations. - Avoid alcohol: concurrent intake can cause a disulfiram‑like reaction. - Use with caution in pregnancy: weigh benefits against potential risks. - Review concomitant medications: evaluate for known drug interactions. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Metronidazole can interact with several medicines; categorize the risk level.

Major Interactions (Avoid): - Alcohol: may cause severe flushing, tachycardia, and hypotension. - Warfarin: potentiates anticoagulant effect, increasing bleeding risk. - Lithium: can raise lithium levels, leading to toxicity. - Carbamazepine: reduces metronidazole concentrations, decreasing efficacy.

Moderate Interactions (Monitor Closely): - Phenytoin: may alter plasma levels of both drugs. - Cimetidine: can increase metronidazole exposure. - Oral contraceptives: may reduce contraceptive effectiveness. - Tacrolimus: may increase tacrolimus levels, requiring dose adjustment.